Medipresso Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $107.89
Latest Deal Amount
  • Investors
  • 6

Medipresso General Information

Description

Producer of medicinal herbal tea intended to combine medicines with the natural ingredients. The company's products include herbal tea in the form of capsules which can be easily consumed, enabling customers to get medicinal value and enjoy their drinks.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Beverages
Other Industries
Specialty Retail
Pharmaceuticals
Primary Office
  • 807, 5, Gasan Digital 1-ro, Geumcheon-gu
  • Daeryung Techno Town 20th
  • Seoul
  • South Korea
+82 00-0000-0000

Medipresso Timeline

2017201820192020
Date FoundedFinancing RoundFinancing Round
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Medipresso Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Seed Round 01-Dec-2019 $107.89 0000.00 Completed Generating Revenue
2. Accelerator/Incubator 01-May-2019 Completed Generating Revenue
1. Angel (individual) 01-Dec-2018 Completed Generating Revenue
To view Medipresso’s complete valuation and funding history, request access »

Medipresso Executive Team (1)

Name Title Board Seat Contact Info
Ha-Seop Kim Chief Executive Officer & Representative
To view Medipresso’s complete executive team members history, request access »

Medipresso Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bluepoint Partners Accelerator/Incubator Minority 000 0000 000000 0
Keiretsu Forum Venture Capital Minority 000 0000 000000 0
Miracle Group (South Korea) Other Minority 000 0000 000000 0
Venture Square Accelerator/Incubator Minority 000 0000 000000 0
D.CAMP Accelerator/Incubator Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »